APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Galidesivir

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Galidesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17399391032 January 2026188 pages

Choose your research edition.

Industry ResearchGalidesivir Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Galidesivir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Galidesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galidesivir Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Galidesivir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Galidesivir market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Galidesivir include BioCryst Pharmaceuticals, Cayman Chemical, ChemScene, CliniSciences, Taiclone and Xi'an Henrikang Biotech Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Galidesivir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Galidesivir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Galidesivir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galidesivir market size, projected growth trends, production technologies, key applications, and end-use industries.

Galidesivir Segment by Company

BioCryst Pharmaceuticals

Cayman Chemical

ChemScene

CliniSciences

Taiclone

Xi'an Henrikang Biotech Co.

Galidesivir Segment by Type

Galidesivir Powder

Galidesivir Hydrochloride

Galidesivir Segment by Application

Yellow Fever

Marburg Virus Disease

Filovirus Infections/Ebola Virus Infection

Galidesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galidesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galidesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galidesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Galidesivir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Galidesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Galidesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Galidesivir Industry Trends Table 2. Galidesivir Industry Drivers Table 3. Galidesivir Industry Opportunities and Challenges Table 4. Galidesivir Industry Restraints Table 5. Global Galidesivir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Galidesivir Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Galidesivir Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Galidesivir Sales Market Share by Manufacturers Table 9. Global Galidesivir Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Galidesivir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Galidesivir Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Galidesivir Manufacturers, Product Type & Application Table 13. Global Galidesivir Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Galidesivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Galidesivir Powder Table 17. Major Manufacturers of Galidesivir Hydrochloride Table 18. Global Galidesivir Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Galidesivir Sales by Type (2021-2026) & (Tons) Table 20. Global Galidesivir Sales by Type (2027-2032) & (Tons) Table 21. Global Galidesivir Sales Market Share by Type (2021-2026) Table 22. Global Galidesivir Sales Market Share by Type (2027-2032) Table 23. Global Galidesivir Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Galidesivir Revenue by Type (2021-2026) & (Tons) Table 25. Global Galidesivir Revenue by Type (2027-2032) & (Tons) Table 26. Global Galidesivir Revenue Market Share by Type (2021-2026) Table 27. Global Galidesivir Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Yellow Fever Table 29. Major Manufacturers of Marburg Virus Disease Table 30. Major Manufacturers of Filovirus Infections/Ebola Virus Infection Table 31. Global Galidesivir Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Galidesivir Sales by Application (2021-2026) & (Tons) Table 33. Global Galidesivir Sales by Application (2027-2032) & (Tons) Table 34. Global Galidesivir Sales Market Share by Application (2021-2026) Table 35. Global Galidesivir Sales Market Share by Application (2027-2032) Table 36. Global Galidesivir Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Galidesivir Revenue by Application (2021-2026) & (Tons) Table 38. Global Galidesivir Revenue by Application (2027-2032) & (Tons) Table 39. Global Galidesivir Revenue Market Share by Application (2021-2026) Table 40. Global Galidesivir Revenue Market Share by Application (2027-2032) Table 41. Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Galidesivir Sales by Region (2021-2026) & (Tons) Table 43. Global Galidesivir Sales Market Share by Region (2021-2026) Table 44. Global Galidesivir Sales Forecasted by Region (2027-2032) & (Tons) Table 45. Global Galidesivir Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 47. North America Galidesivir Sales by Country (2021-2026) & (Tons) Table 48. North America Galidesivir Sales by Country (2027-2032) & (Tons) Table 49. Europe Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. Europe Galidesivir Sales by Country (2021-2026) & (Tons) Table 51. Europe Galidesivir Sales by Country (2027-2032) & (Tons) Table 52. Asia Pacific Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Asia Pacific Galidesivir Sales by Country (2021-2026) & (Tons) Table 54. Asia Pacific Galidesivir Sales by Country (2027-2032) & (Tons) Table 55. South America, Middle East and Africa Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. South America, Middle East and Africa Galidesivir Sales by Country (2021-2026) & (Tons) Table 57. South America, Middle East and Africa Galidesivir Sales by Country (2027-2032) & (Tons) Table 58. Global Galidesivir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Galidesivir Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Galidesivir Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Galidesivir Revenue Market Share by Region (2021-2026) Table 62. Global Galidesivir Revenue Market Share by Region (2027-2032) Table 63. BioCryst Pharmaceuticals Company Information Table 64. BioCryst Pharmaceuticals Business Overview Table 65. BioCryst Pharmaceuticals Galidesivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. BioCryst Pharmaceuticals Galidesivir Product Portfolio Table 67. BioCryst Pharmaceuticals Recent Development Table 68. Cayman Chemical Company Information Table 69. Cayman Chemical Business Overview Table 70. Cayman Chemical Galidesivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cayman Chemical Galidesivir Product Portfolio Table 72. Cayman Chemical Recent Development Table 73. ChemScene Company Information Table 74. ChemScene Business Overview Table 75. ChemScene Galidesivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. ChemScene Galidesivir Product Portfolio Table 77. ChemScene Recent Development Table 78. CliniSciences Company Information Table 79. CliniSciences Business Overview Table 80. CliniSciences Galidesivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CliniSciences Galidesivir Product Portfolio Table 82. CliniSciences Recent Development Table 83. Taiclone Company Information Table 84. Taiclone Business Overview Table 85. Taiclone Galidesivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Taiclone Galidesivir Product Portfolio Table 87. Taiclone Recent Development Table 88. Xi'an Henrikang Biotech Co. Company Information Table 89. Xi'an Henrikang Biotech Co. Business Overview Table 90. Xi'an Henrikang Biotech Co. Galidesivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio Table 92. Xi'an Henrikang Biotech Co. Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Galidesivir Distributors List Table 96. Galidesivir Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Galidesivir Product Image Figure 2. Global Galidesivir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galidesivir Market Size (2021-2032) & (US$ Million) Figure 4. Global Galidesivir Sales (2021-2032) & (Tons) Figure 5. Global Galidesivir Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Galidesivir Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Galidesivir Powder Image Figure 9. Galidesivir Hydrochloride Image Figure 10. Global Galidesivir Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Galidesivir Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Galidesivir Sales Market Share by Type (2021-2032) Figure 13. Global Galidesivir Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Galidesivir Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Galidesivir Revenue Market Share by Type (2021-2032) Figure 16. Yellow Fever Image Figure 17. Marburg Virus Disease Image Figure 18. Filovirus Infections/Ebola Virus Infection Image Figure 19. Global Galidesivir Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Galidesivir Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Galidesivir Sales Market Share by Application (2021-2032) Figure 22. Global Galidesivir Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Galidesivir Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Galidesivir Revenue Market Share by Application (2021-2032) Figure 25. North America Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 26. North America Galidesivir Sales Market Share by Country (2021-2032) Figure 27. U.S. Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Canada Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Mexico Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Galidesivir Sales Market Share by Country (2021-2032) Figure 32. Germany Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 33. France Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 34. U.K. Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Italy Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Netherlands Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Galidesivir Sales Market Share by Country (2021-2032) Figure 39. China Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Japan Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 41. South Korea Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Southeast Asia Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 43. India Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Australia Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Galidesivir Sales Market Share by Country (2021-2032) Figure 47. Brazil Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South Africa Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Saudi Arabia Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Turkey Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Argentina Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 52. UAE Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Egypt Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Chile Galidesivir Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Global Galidesivir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Galidesivir Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Galidesivir Revenue (2021-2032) & (US$ Million) Figure 58. North America Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Galidesivir Revenue (2021-2032) & (US$ Million) Figure 60. Europe Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Galidesivir Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Galidesivir Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Galidesivir Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Galidesivir Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Galidesivir Powder
  • Galidesivir Hydrochloride
Applications
  • Yellow Fever
  • Marburg Virus Disease
  • Filovirus Infections/Ebola Virus Infection
Companies covered
  • BioCryst Pharmaceuticals
  • Cayman Chemical
  • ChemScene
  • CliniSciences
  • Taiclone
  • Xi'an Henrikang Biotech Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Galidesivir Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Galidesivir Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Galidesivir Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Galidesivir Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Galidesivir Market Dynamics
  1. 2.1 Galidesivir Industry Trends
  2. 2.2 Galidesivir Industry Drivers
  3. 2.3 Galidesivir Industry Opportunities and Challenges
  4. 2.4 Galidesivir Industry Restraints
3 Galidesivir Market by Manufacturers
  1. 3.1 Global Galidesivir Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Galidesivir Sales by Manufacturers (2021-2026)
  3. 3.3 Global Galidesivir Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Galidesivir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Galidesivir Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Galidesivir Manufacturers, Product Type & Application
  7. 3.7 Global Galidesivir Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Galidesivir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Galidesivir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Galidesivir Tier 1, Tier 2, and Tier 3
4 Galidesivir Market by Type
  1. 4.1 Galidesivir Type Introduction
  2. 4.1.1 Galidesivir Powder
  3. 4.1.2 Galidesivir Hydrochloride
  4. 4.2 Global Galidesivir Sales by Type
  5. 4.2.1 Global Galidesivir Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Galidesivir Sales by Type (2021-2032)
  7. 4.2.3 Global Galidesivir Sales Market Share by Type (2021-2032)
  8. 4.3 Global Galidesivir Revenue by Type
  9. 4.3.1 Global Galidesivir Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Galidesivir Revenue by Type (2021-2032)
  11. 4.3.3 Global Galidesivir Revenue Market Share by Type (2021-2032)
5 Galidesivir Market by Application
  1. 5.1 Galidesivir Application Introduction
  2. 5.1.1 Yellow Fever
  3. 5.1.2 Marburg Virus Disease
  4. 5.1.3 Filovirus Infections/Ebola Virus Infection
  5. 5.2 Global Galidesivir Sales by Application
  6. 5.2.1 Global Galidesivir Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Galidesivir Sales by Application (2021-2032)
  8. 5.2.3 Global Galidesivir Sales Market Share by Application (2021-2032)
  9. 5.3 Global Galidesivir Revenue by Application
  10. 5.3.1 Global Galidesivir Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Galidesivir Revenue by Application (2021-2032)
  12. 5.3.3 Global Galidesivir Revenue Market Share by Application (2021-2032)
6 Global Galidesivir Sales by Region
  1. 6.1 Global Galidesivir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Galidesivir Sales by Region (2021-2032)
  3. 6.2.1 Global Galidesivir Sales by Region (2021-2026)
  4. 6.2.2 Global Galidesivir Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Galidesivir Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Galidesivir Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Galidesivir Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Galidesivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Galidesivir Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Galidesivir Revenue by Region
  1. 7.1 Global Galidesivir Revenue by Region
  2. 7.1.1 Global Galidesivir Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Galidesivir Revenue by Region (2021-2026)
  4. 7.1.3 Global Galidesivir Revenue by Region (2027-2032)
  5. 7.1.4 Global Galidesivir Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Galidesivir Revenue (2021-2032)
  8. 7.2.2 North America Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Galidesivir Revenue (2021-2032)
  11. 7.3.2 Europe Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Galidesivir Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Galidesivir Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Galidesivir Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BioCryst Pharmaceuticals
  2. 8.1.1 BioCryst Pharmaceuticals Company Information
  3. 8.1.2 BioCryst Pharmaceuticals Business Overview
  4. 8.1.3 BioCryst Pharmaceuticals Galidesivir Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BioCryst Pharmaceuticals Galidesivir Product Portfolio
  6. 8.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 8.2 Cayman Chemical
  8. 8.2.1 Cayman Chemical Company Information
  9. 8.2.2 Cayman Chemical Business Overview
  10. 8.2.3 Cayman Chemical Galidesivir Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cayman Chemical Galidesivir Product Portfolio
  12. 8.2.5 Cayman Chemical Recent Developments
  13. 8.3 ChemScene
  14. 8.3.1 ChemScene Company Information
  15. 8.3.2 ChemScene Business Overview
  16. 8.3.3 ChemScene Galidesivir Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ChemScene Galidesivir Product Portfolio
  18. 8.3.5 ChemScene Recent Developments
  19. 8.4 CliniSciences
  20. 8.4.1 CliniSciences Company Information
  21. 8.4.2 CliniSciences Business Overview
  22. 8.4.3 CliniSciences Galidesivir Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CliniSciences Galidesivir Product Portfolio
  24. 8.4.5 CliniSciences Recent Developments
  25. 8.5 Taiclone
  26. 8.5.1 Taiclone Company Information
  27. 8.5.2 Taiclone Business Overview
  28. 8.5.3 Taiclone Galidesivir Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taiclone Galidesivir Product Portfolio
  30. 8.5.5 Taiclone Recent Developments
  31. 8.6 Xi'an Henrikang Biotech Co.
  32. 8.6.1 Xi'an Henrikang Biotech Co. Company Information
  33. 8.6.2 Xi'an Henrikang Biotech Co. Business Overview
  34. 8.6.3 Xi'an Henrikang Biotech Co. Galidesivir Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio
  36. 8.6.5 Xi'an Henrikang Biotech Co. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Galidesivir Value Chain Analysis
  2. 9.1.1 Galidesivir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Galidesivir Production Mode & Process
  6. 9.2 Galidesivir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Galidesivir Distributors
  9. 9.2.3 Galidesivir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst